MW Does a test
Headline subtitle
test schedule
RadioMedix wins FDA approval for generic Ga-68 PSMA-11 PET agent
Linnaeus Therapeutics' LNS8801 selected for NIA lifespan testing
Nyxoah raises $110m to accelerate Genio sleep apnoea launch in US
Cartesian licenses mRNA payload to WestGene for in vivo CAR-T
Cullinan Therapeutics reports remissions in SLE and RA with CD19 TCE
Tectonic Therapeutic completes APEX Phase 2 enrolment for TX45
Humacyte ATEV beats AV fistula on catheter-free days in Phase 3
Tris Pharma wins FDA Orphan Drug Designation for TRN-257 in IH
Optimi Health ships psilocybin to UK for Phase 2 clinical trial
CONNECTA Therapeutics starts Phase IIa trial of CTH120 in fragile X
Windward Bio doses first patients in Phase 2 COPD study of WIN378
Actuate Therapeutics' elraglusib enters BEACON2 neuroblastoma trial
Alterity Therapeutics wins FDA alignment on ATH434 Phase 3 MSA trial
Ceribell Clarity AI links seizure burden to neurological outcomes
Cellectis wins FDA RMAT designation for allogeneic CAR-T lasme-cel